Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
Motoko Kanno(The Cancer Institute Hospital), Hiroyuki Kanao(Japanese Foundation For Cancer Research), Sanshiro Okamoto(The Cancer Institute Hospital), Maki Matoda(The Cancer Institute Hospital), Makoto Nakabayashi(The Cancer Institute Hospital), Sachiho Netsu(The Cancer Institute Hospital), Terumi Tanigawa(The Cancer Institute Hospital), Atsushi Fusegi(Japanese Foundation For Cancer Research), Ai Ikki(The Cancer Institute Hospital), Kohei Omatsu(The Cancer Institute Hospital), Nobuhiro Takeshima, Tomoko Kurita(The Cancer Institute Hospital), Yoichi Aoki(The Cancer Institute Hospital), Hidetaka Nomura(Japanese Foundation For Cancer Research), Kota Okamoto(The Cancer Institute Hospital), Mayu Yunokawa(Japanese Foundation For Cancer Research), Yuko Sugiyama, Mai Nishimura(The Cancer Institute Hospital), Yuji Tanaka(Shiga University of Medical Science), Yusuke Shimizu(The Cancer Institute Hospital), Makiko Omi(Japanese Foundation For Cancer Research), Kuniko Utsugi(The Cancer Institute Hospital), Megumi Mizusaki(The Cancer Institute Hospital)
Cited by 16
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
|Gynecologic Oncology|2019|121
Utility of the Monoclonal Antibody HIK1083 in the Diagnosis of Adenoma Malignum of the Uterine Cervix
|Gynecologic Oncology|1999|65
Parametrial Involvement in FIGO Stage IB1 Cervical Carcinoma: Diagnostic Impact of Tumor Diameter in Preoperative Magnetic Resonance Imaging
|International Journal of Gynecological Cancer|2011|55
Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH
|American Journal of Obstetrics and Gynecology|2004|38